Limitations and advances in new treatments and future perspectives of corneal blindness

Arq Bras Oftalmol. May-Jun 2021;84(3):282-296. doi: 10.5935/0004-2749.20210042.

Abstract

This review is intended to describe the therapeutic approaches for corneal blindness, detailing the steps and elements involved in corneal wound healing. It also presents the limitations of the actual surgical and pharmacological strategies used to restore and maintain corneal transparency in terms of long-term survival and geographic coverage. In addition, we critically review the perspectives of anabolic agents, including vitamin A, hormones, growth factors, and novel promitotic and anti-inflammatory modulators, to assist corneal wound healing. We discuss the studies involving nanotechnology, gene therapy, and tissue reengineering as potential future strategies to work solely or in combination with corneal surgery to prevent or revert corneal blindness.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Blindness
  • Cornea*
  • Corneal Injuries*
  • Humans
  • Wound Healing

Substances

  • Anti-Inflammatory Agents